WORK Medical Technology Group (NASDAQ:WOK) vs. 908 Devices (NASDAQ:MASS) Head to Head Contrast

WORK Medical Technology Group (NASDAQ:WOK) and 908 Devices (NASDAQ:MASS) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, dividends, analyst recommendations and valuation.

Analyst Recommendations

This is a summary of current ratings and recommmendations for WORK Medical Technology Group and 908 Devices, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
WORK Medical Technology Group	1	0	0	0	1.00
908 Devices	1	0	1	0	2.00

908 Devices has a consensus target price of $12.00, suggesting a potential upside of 71.92%. Given 908 Devices’ stronger consensus rating and higher possible upside, analysts clearly believe 908 Devices is more favorable than WORK Medical Technology Group.

Profitability

This table compares WORK Medical Technology Group and 908 Devices’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
WORK Medical Technology Group	N/A	N/A	N/A
908 Devices	-62.40%	-14.03%	-10.40%

Volatility & Risk

WORK Medical Technology Group has a beta of 2.37, suggesting that its stock price is 137% more volatile than the S&P 500. Comparatively, 908 Devices has a beta of 0.57, suggesting that its stock price is 43% less volatile than the S&P 500.

Earnings and Valuation

This table compares WORK Medical Technology Group and 908 Devices”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
WORK Medical Technology Group	$9.81 million	0.00	-$1.07 million	N/A	N/A
908 Devices	$57.80 million	4.57	$19.49 million	($1.00)	-6.98

908 Devices has higher revenue and earnings than WORK Medical Technology Group.

Institutional and Insider Ownership

88.1% of 908 Devices shares are owned by institutional investors. 28.2% of 908 Devices shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

908 Devices beats WORK Medical Technology Group on 8 of the 12 factors compared between the two stocks.

About WORK Medical Technology Group

WORK Medical Technology Group Ltd. engages in developing health instruments. It manufactures and sells medical devices, including endotracheal tubes, laryngeal mask airways, heat and moisture exchanging filters, disposable breathing circuits, nebulizer kits, and yankauer suction sets. The company was founded on March 1, 2022 and is headquartered in Hangzhou, China.

About 908 Devices

908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling. Its products also comprise Maven and Trace C2, an online device for bioprocess monitoring and control; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. The company operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of the Americas. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.